ERBB2 and breast carcinoma: Typically, these vaccines target well-known TAAs such as Mam-A or HER2 in breast cancer, prostatic acid phosphatase (PAP) in prostate cancer, and oncoviral antigens such as the E6/7 HPV protein in cervical cancer [120].